Evidence map›Paper›PMID 27934801›Full record

ArticleThe Indian journal of medical research2016

Derivation & validation of glycosylated haemoglobin (HbA

Alladi Mohan, S Aparna Reddy, Alok Sachan, Kvs Sarma, D Prabath Kumar, Mahesh V Panchagnula, Pvln Srinivasa Rao, B Siddhartha Kumar, P Krishnaprasanthi

Open access · diamondAbstract read
In one paragraph

Article in The Indian journal of medical research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Intermediate hyperglycaemia and 10-year mortality in resource-constrained settings: the PERU MIGRANT Study.Diabetic medicine : a journal of the British Diabetic Association · 2020
    Article
  3. Article
  4. Authors' Response.The Indian journal of medical research · 2017
    Article
  5. Comparison of Hemoglobin AIndian journal of endocrinology and metabolism
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Alladi MohanDepartment of Medicine, Sri Venkateswara Institute of Medical Sciences, Tirupati, India.
S Aparna ReddyDepartment of Medicine, Sri Venkateswara Institute of Medical Sciences, Tirupati, India.
Alok SachanDepartment of Endocrinology and Metabolism, Sri Venkateswara Institute of Medical Sciences, Tirupati, India.
Kvs SarmaDepartment of Statistics, Sri Venkateswara University, Tirupati, India.
D Prabath KumarDepartment of Medicine, Sri Venkateswara Institute of Medical Sciences, Tirupati, India.
Mahesh V PanchagnulaDepartment of Applied Mechanics, Indian Institute of Technology Madras, Chennai, India.
Pvln Srinivasa RaoDepartment of Biochemistry, Sri Venkateswara Institute of Medical Sciences, Tirupati, India.
B Siddhartha KumarDepartment of Medicine, Sri Venkateswara Institute of Medical Sciences, Tirupati, India.
P KrishnaprasanthiDepartment of General Medicine, Harshitha Hospital, Tirupati, India.
Sri Venkateswara Institute of Medical Sciences · INIndian Institute of Technology Madras · INSri Venkateswara University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND &

objectivesGlycosylated haemoglobin (HbA 1c ) has been in use for more than a decade, as a diagnostic test for type 2 diabetes. Validity of HbA 1c needs to be established in the ethnic population in which it is intended to be used. The objective of this study was to derive and validate a HbA 1c cut-off value for the diagnosis of type 2 diabetes in the ethnic population of Rayalaseema area of south India.

methodsIn this cross-sectional study, consecutive patients suspected to have type 2 diabetes underwent fasting plasma glucose (FPG) and 2 h post-load plasma glucose (2 h-PG) measurements after a 75 g glucose load and HbA 1c estimation. They were classified as having diabetes as per the American Diabetes Association criteria [(FPG ≥7 mmol/l (≥126 mg/dl) and/or 2 h-PG ≥11.1 mmol/l (≥200 mg/dl)]. In the training data set (n = 342), optimum cut-off value of HbA 1c for defining type 2 diabetes was derived by receiver-operator characteristic (ROC) curve method using oral glucose tolerance test results as gold standard. This cut-off was validated in a validation data set (n = 341).

resultsOn applying HbA 1c cut-off value of >6.3 per cent (45 mmol/mol) to the training data set,sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) for diagnosing type 2 diabetes were calculated to be 90.6, 85.2, 80.8 and 93.0 per cent, respectively. When the same cut-off value was applied to the validation data set, sensitivity, specificity, PPV and NPV were 88.8 , 81.9, 74.0 and 92.7 per cent, respectively, although the latter were consistently smaller than the proportions for the training data set, the differences being not significant. INTERPRETATION &

conclusionsHbA 1c >6.3 per cent (45 mmol/mol) appears to be the optimal cut-off value for the diagnosis of type 2 diabetes applicable to the ethnic population of Rayalaseema area of Andhra Pradesh state in south India.

Indexed as

AdultBlood GlucoseCross-Sectional StudiesDiabetes Mellitus, Type 2EthnicityFemaleGlucose Tolerance TestGlycated HemoglobinHumansIndiaMaleMiddle AgedBlood GlucoseGlycated Hemoglobin

Identifiers

PMID27934801
PMCPMC5206873
OpenAlexW2557402911

What Socratic holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.